KR20220136107A - Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same - Google Patents
Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same Download PDFInfo
- Publication number
- KR20220136107A KR20220136107A KR1020220026498A KR20220026498A KR20220136107A KR 20220136107 A KR20220136107 A KR 20220136107A KR 1020220026498 A KR1020220026498 A KR 1020220026498A KR 20220026498 A KR20220026498 A KR 20220026498A KR 20220136107 A KR20220136107 A KR 20220136107A
- Authority
- KR
- South Korea
- Prior art keywords
- aloe
- fermented
- lactic acid
- powder
- acid bacteria
- Prior art date
Links
- 235000011399 aloe vera Nutrition 0.000 title claims abstract description 131
- 241001116389 Aloe Species 0.000 title claims abstract description 102
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims description 82
- 241000894006 Bacteria Species 0.000 title claims description 45
- 235000014655 lactic acid Nutrition 0.000 title claims description 41
- 239000004310 lactic acid Substances 0.000 title claims description 41
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 239000000843 powder Substances 0.000 claims abstract description 76
- 238000000855 fermentation Methods 0.000 claims abstract description 34
- 230000004151 fermentation Effects 0.000 claims abstract description 34
- 229930003935 flavonoid Natural products 0.000 claims abstract description 21
- 235000017173 flavonoids Nutrition 0.000 claims abstract description 21
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 18
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 18
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 18
- 230000036541 health Effects 0.000 claims abstract description 15
- 235000013376 functional food Nutrition 0.000 claims abstract description 13
- 239000004615 ingredient Substances 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims description 21
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 18
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 17
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 10
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 9
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 9
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 9
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 9
- 241001608472 Bifidobacterium longum Species 0.000 claims description 8
- 108010059892 Cellulase Proteins 0.000 claims description 6
- 108010059820 Polygalacturonase Proteins 0.000 claims description 6
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 6
- 229940106157 cellulase Drugs 0.000 claims description 6
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 241000186000 Bifidobacterium Species 0.000 claims description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 abstract description 29
- 230000003078 antioxidant effect Effects 0.000 abstract description 14
- 240000007474 Aloe arborescens Species 0.000 abstract description 5
- 235000004509 Aloe arborescens Nutrition 0.000 abstract description 5
- 241000186660 Lactobacillus Species 0.000 abstract description 4
- 229940039696 lactobacillus Drugs 0.000 abstract description 4
- 208000008589 Obesity Diseases 0.000 abstract description 3
- 235000020824 obesity Nutrition 0.000 abstract description 3
- 244000186892 Aloe vera Species 0.000 abstract 1
- 239000000047 product Substances 0.000 description 36
- 244000144927 Aloe barbadensis Species 0.000 description 28
- 108090000790 Enzymes Proteins 0.000 description 20
- 102000004190 Enzymes Human genes 0.000 description 20
- 229940088598 enzyme Drugs 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 9
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 235000014104 aloe vera supplement Nutrition 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000010421 standard material Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 244000242092 Aloe saponaria Species 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 1
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000009369 viticulture Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2102—Aloe
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2116—Flavonoids, isoflavones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2132—Other phenolic compounds, polyphenols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 유용성분 함량이 증가된 알로에 유산균 발효물 및 상기 발효물을 이용한 알로에 발효 포스트바이오틱스 유산균의 제조방법에 관한 것이다.The present invention relates to a fermented product of aloe lactic acid bacteria having an increased content of useful components, and a method for producing an aloe fermented postbiotic lactic acid bacteria using the fermented product.
유산균은 인간이 이용할 수 있는 가장 유익한 미생물 중의 한 종류로서, 비병원성균으로 인간의 장내에 서식하면서 정장 및 정균작용을 할 수 있고 당류를 발효해서 다량의 젖산을 생성하고 낮은 pH 및 혐기적인 조건에서도 잘 생육하며 여러 가지 영양물질을 요구하는 등의 특징을 가지고 있다. 유산균에 의해 채소류가 발효되면 독특한 향과 맛을 내게 되어 관능적 특성이 향상되고, 유기산에 의하여 비타민 C와 여러 생리활성물질이 잘 보존되며, 초기 재료에는 거의 존재하지 않았던 비타민 B12와 비타민 K가 생합성되어 부패균과 병원성균의 성장과 증식을 저해하여 위생적인 식품이 되는 등의 장점을 가지고 있는 것으로 알려져 있다.Lactobacillus is one of the most beneficial microorganisms available to humans. As a non-pathogenic bacteria, it can perform intestinal and bacteriostatic effects while inhabiting the human intestine. It has the characteristics of growing and requiring various nutrients. When vegetables are fermented by lactic acid bacteria, their unique flavor and taste are improved, and the sensory properties are improved, and vitamin C and various physiologically active substances are well preserved by organic acids. It is known to have the advantage of becoming a hygienic food by inhibiting the growth and proliferation of putrefactive and pathogenic bacteria.
알로에는 백합과(Liliaceae) 알로에속(Aloineae)에 속하는 다년생 다육식물로 노회, 나무노회라고도 하는데 이는 알로에의 '로에'를 음차한 것에 기인한다. 주로 중동, 마다가스카르, 아프리카 남부가 원산지로 총 600여 종류가 알려져 있다. 전 세계적으로 주로 약용 및 식용으로 사용되는 것은 알로에 베라(Aloe vera), 알로에 아보레센스(A. aborescens), 알로에 사포나리아(A. saponaria) 등 6~7종에 불과하며, 국내에서는 알로에 베라와 알로에 아보레센스가 제주도 등지에서 주로 재배되고 있다.Aloe is a perennial succulent plant belonging to the genus Aloineae of the Liliaceae family. It is mainly native to the Middle East, Madagascar, and southern Africa, and a total of 600 species are known. There are only 6-7 species, including Aloe vera , A. aborescens , and A. saponaria , that are mainly used for medicinal and edible purposes worldwide. Aloe arborescens is mainly cultivated in Jeju Island and other areas.
알로에는 지방산, 유기산, 플라보노이드 등 200여 가지의 화합물을 함유하고 있는 것으로 알려져 있으며, 당단백질, 다당체 등의 저분자 물질인 식물성 페놀류인 안트라퀴논(Anthraquinone)계, 안트론(Anthrone)계, 크로몬(Chromome)류, 피론(Pyrone)류, 아미노산, 비타민과 미네랄 등의 성분이 포함되어 있다고 알려져 있다. 파이토케미컬인 식물성 페놀류 중 안트라퀴논계인 알로인(aloin)은 장 속의 수분량을 늘리고 장 운동을 활발히 하는데 도움을 줘 변비 개선에 도움을 주는 것이 알려져 있으며, 알로에의 다당체는 장 속의 유익균 생장에 도움을 줘 장 건강을 개선하는 효과를 가져 올 수 있고, 알로에 베라로부터 분리된 당단백질인 NY 945는 히스타민 등의 매개체 분비를 억제하며 호산구의 조직 내 침윤을 억제함으로써 항알레르기 효과를 나타낸다고 보고되고 있다. 또한 위액의 분비를 촉진시키며 소화 작용을 활발하게 하여 소화불량 개선 효과가 있는 알로에몬을 함유하고 있으며, 알로에 우르신이 위벽을 위산으로부터 보호하는 것이 잘 알려져 있어 위 건강 유지에 도움을 줄 수 있다.Aloe is known to contain more than 200 compounds such as fatty acids, organic acids, and flavonoids. Chromome), pyrones, amino acids, vitamins and minerals are known to contain. Among the phytochemical plant phenols, aloin, an anthraquinone type, is known to help improve constipation by increasing the amount of water in the intestine and helping to promote bowel movements. It is reported that NY 945, a glycoprotein isolated from aloe vera, suppresses the secretion of mediators such as histamine and suppresses the infiltration of eosinophils into tissues, thereby exhibiting an anti-allergic effect. It also contains aloemon, which has the effect of improving indigestion by stimulating the secretion of gastric juice and activating digestion.
한편, 한국등록특허 제1502219호에는 '알로에 효소 추출물 또는 이의 분획물을 함유하는 항산화 조성물'이 개시되어 있고, 한국공개특허 제2020-0080189호에는 '고농도의 페놀 화합물을 함유하는 알로에속 식물 추출물의 제조방법 및 그 방법을 이용하여 제조된 추출물을 포함하는 피부 재생, 항염 및/또는 항산화용 조성물'이 개시하되어 있으나, 이는 알로에의 생리활성물질을 일부 효소처리와 추출법 등을 사용하여 수득하는 방법에 관한 것으로써, 상기 문헌에는 본 발명의 '유용성분 함량이 증가된 알로에 유산균 발효물 및 상기 발효물을 이용한 알로에 발효 포스트바이오틱스 유산균의 제조방법'에 대해서는 아직까지 개시된 바가 없다. 또한 알로에는 최근 국내 많은 연구를 통해 그 효능이 입증되고 있으나 알로에로부터 추출한 단일 성분에 관한 연구가 대부분이며 이 또한 주로 알로에의 껍질을 제거한 알로에 겔 성분을 중심으로 연구가 이루어져 있다. 산업적으로도 알로에에 함유되어 있는 성분의 추출물을 제한적으로 활용하고 있는 것이 현실이다. 따라서 알로에가 가지고 있는 생리활성 물질을 증가시키는 연구나 가공기술이 요구되고 있다.On the other hand, Korean Patent No. 1502219 discloses 'an antioxidant composition containing an aloe enzyme extract or a fraction thereof', and Korean Patent Application Publication No. 2020-0080189 discloses 'Preparation of an aloe plant extract containing a high concentration of phenolic compounds' Although a method and a composition for skin regeneration, anti-inflammatory and/or antioxidant comprising an extract prepared using the method are disclosed, this is a method for obtaining a physiologically active substance of aloe using some enzyme treatment and extraction method. In this regard, the literature does not yet disclose the 'fermented product of aloe lactic acid bacteria having an increased content of useful components and a method for producing aloe fermented postbiotic lactic acid bacteria using the fermented product' of the present invention. In addition, although the efficacy of aloe has been proven through many domestic studies in recent years, most studies have been done on a single ingredient extracted from aloe, and this study mainly focuses on the aloe gel ingredient from which the skin of aloe has been removed. The reality is that industrially, extracts of ingredients contained in aloe are being used to a limited extent. Therefore, research or processing technology to increase the physiologically active substances possessed by aloe is required.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 알로에 베라 및 알로에 아모레센스의 겔 또는 분말 추출액에 식용배지를 투입하여 멸균한 후 락토바실러스 플랜타룸 CBG-C21(Lactobacillus plantarum CBG-C21) 균주 또는 셀룰라아제(cellulase)와 펙티나제(Pectinase)를 상기 균주와 동시에 처리하여 1차 알로에 발효물을 제조한 후, 비피도박테리움 애니말리스(Bifidobacterium animalis), 락토바실러스 플랜타룸(L. plantarum), 락토바실러스 람노서스(L. rhamnosus), 비피도박테리움 롱검(B. longum) 및 스트렙토코커스 써모필러스(Streptococcus thermophilus)를 추가 접종, 발효하여 제조된 2차 알로에 발효물에 동결보호제를 투입하여 동결건조분말을 제조하였을 때, 상기 최종 생산된 동결건조분말이 발효 전에 비해 총 폴리페놀 및 총 플라보노이드 함량 증가와 항산화 활성이 현저하게 증가되는 것을 확인함으로써, 본 발명을 완성하였다.The present invention has been derived from the above needs, and the present inventors put an edible medium into the gel or powder extract of Aloe vera and Aloe amoresense and sterilize it, and then Lactobacillus plantarum CBG-C21 ( Lactobacillus plantarum CBG-C21) After preparing a primary aloe fermented product by treating the strain or cellulase and pectinase simultaneously with the strain, Bifidobacterium animalis , Lactobacillus plantarum ( L. plantarum ) , Lactobacillus rhamnosus ( L. rhamnosus ), Bifidobacterium longum ( B. longum ), and Streptococcus thermophilus ( Streptococcus thermophilus ) By adding a cryoprotectant to the fermented secondary aloe prepared by additional inoculation and fermentation When the freeze-dried powder was prepared, the present invention was completed by confirming that the finally produced freeze-dried powder had an increase in total polyphenol and total flavonoid content and significantly increased antioxidant activity compared to before fermentation.
상기 과제를 해결하기 위하여, 본 발명은 1) 알로에와 식용배지의 혼합물을 제조하는 단계; 2) 상기 1) 단계의 알로에 혼합물에 유산균을 접종하여 1차 발효하는 단계; 및 3) 상기 2) 단계의 알로에 발효물에 혼합균주를 접종하여 2차 발효하는 단계;를 포함하는 유용성분의 함량이 증가된 알로에 발효물의 제조 방법을 제공한다.In order to solve the above problems, the present invention provides the steps of 1) preparing a mixture of aloe and an edible medium; 2) inoculating lactic acid bacteria into the aloe mixture of step 1) and performing primary fermentation; and 3) inoculating the mixed strain into the fermented aloe of step 2) and performing secondary fermentation.
또한, 본 발명은 상기 방법에 의해 제조된 유용성분의 함량이 증가된 알로에 발효물을 제공한다.The present invention also provides a fermented aloe product having an increased content of useful ingredients prepared by the above method.
또한, 본 발명은 상기 알로에 발효물 또는 이의 건조물을 유효성분으로 포함하는 포스트바이오틱스 유산균을 제공한다.In addition, the present invention provides a postbiotic lactic acid bacterium comprising the fermented aloe or a dried product thereof as an active ingredient.
또한, 본 발명은 상기 알로에 발효물, 이의 건조물, 또는 본 발명의 포스트바이오틱스 유산균을 유효성분으로 함유하는 건강기능식품 조성물을 제공한다.The present invention also provides a health functional food composition comprising the fermented aloe, a dried product thereof, or the postbiotic lactic acid bacteria of the present invention as an active ingredient.
본 발명은 유산균 발효 단독 또는 효소 처리 후 유산균 발효를 이용하여 총 폴리페놀, 총 플라보노이드의 함량이 증가된 알로에 발효물 및 알로에 발효 포스트바이오틱스 유산균을 제공함으로써, 항산화 작용, 비만 예방, 면역 증진 등을 위한 건강기능식품에 유용하게 이용할 수 있다.The present invention provides an aloe fermented product with an increased content of total polyphenols and total flavonoids and aloe fermented postbiotic lactic acid bacteria using lactic acid bacteria fermentation alone or enzyme treatment followed by lactic acid fermentation, thereby providing antioxidant activity, prevention of obesity, immunity enhancement, etc. It can be usefully used in health functional food for
도 1은 본 발명에 따른 알로에 발효물의 제조 공정의 모식도로, 분말 발효법(A)과 겔 발효법(B)을 나타낸 것이다.1 is a schematic diagram of a manufacturing process of fermented aloe according to the present invention, showing a powder fermentation method (A) and a gel fermentation method (B).
본 발명의 목적을 달성하기 위하여, 본 발명은 1) 알로에와 식용배지의 혼합물을 제조하는 단계; 2) 상기 1) 단계의 알로에 혼합물에 유산균을 접종하여 1차 발효하는 단계; 및 3) 상기 2) 단계의 알로에 발효물에 혼합균주를 접종하여 2차 발효하는 단계;를 포함하는 유용성분의 함량이 증가된 알로에 발효물의 제조 방법을 제공한다.In order to achieve the object of the present invention, the present invention comprises the steps of 1) preparing a mixture of aloe and an edible medium; 2) inoculating lactic acid bacteria into the aloe mixture of step 1) and performing primary fermentation; and 3) inoculating the mixed strain into the fermented aloe of step 2) and performing secondary fermentation.
본 발명에 따른 제조 방법에 있어서, 상기 1) 단계의 알로에는 알로에 분말 추출물 또는 알로에 겔일 수 있으나, 이에 제한되지 않는다. 또한, 상기 알로에는 알로에 베라(Aloe vera) 또는 알로에 아보레센스(Aloe aborescens)일 수 있으나, 이에 제한되지 않는다.In the preparation method according to the present invention, the aloe in step 1) may be an aloe powder extract or aloe gel, but is not limited thereto. In addition, the aloe may be Aloe vera or Aloe aborescens , but is not limited thereto.
또한, 상기 1) 단계의 식용배지는 이에 한정되는 것은 아니나, 바람직하게는 0.5~2%(w/v)의 소이펩톤 및 1~5%(w/v)의 글루코스로 이루어진 것일 수 있다.In addition, the edible medium of step 1) is not limited thereto, but preferably 0.5 to 2% (w/v) of soipeptone and 1 to 5% (w/v) of glucose.
본 발명에 따른 제조 방법에 있어서, 상기 2) 단계의 1차 발효는 1) 단계의 알로에 혼합물에 기탁번호가 KACC92083P인 락토바실러스 플랜타룸 CBG-C21(Lactobacillus plantarum CBG-C21) 균주를 1.0x108 내지 1.0x109 CFU/㎖로 접종하여 발효하거나; 1) 단계의 알로에 혼합물에 셀룰라아제(cellulase) 및 펙티나제(pectinase)를 처리하고, 동시에 기탁번호가 KACC92083P인 락토바실러스 플랜타룸 CBG-C21 균주를 1.0x108 내지 1.0x109 CFU/㎖로 접종하여 35~39℃의 온도에서 20~28시간 동안 교반하며 발효하는 것일 수 있으나, 이에 제한되지 않는다.In the production method according to the present invention, the primary fermentation of step 2) is performed by adding a Lactobacillus plantarum CBG-C21 strain having an accession number of KACC92083P to the aloe mixture of step 1) from 1.0x10 8 to fermented by inoculation at 1.0x10 9 CFU/ml; The aloe mixture of step 1) was treated with cellulase and pectinase, and at the same time, the Lactobacillus plantarum CBG-C21 strain having an accession number of KACC92083P was inoculated at 1.0x10 8 to 1.0x10 9 CFU/ml. It may be fermentation while stirring for 20-28 hours at a temperature of 35-39 ℃, but is not limited thereto.
또한, 상기 셀룰라아제와 펙티나제는 0.1~0.5%(w/v) 및 0.01~0.2%(w/v)의 농도로 처리되는 것일 수 있으나, 이에 제한되지 않는다.In addition, the cellulase and pectinase may be treated at a concentration of 0.1 to 0.5% (w/v) and 0.01 to 0.2% (w/v), but is not limited thereto.
본 발명에 따른 제조 방법에 있어서, 상기 3) 단계의 혼합균주는 비피도박테리움 애니말리스(Bifidobacterium animalis), 락토바실러스 플랜타룸(Lactobacillus plantarum), 락토바실러스 람노서스(Lactobacillus rhamnosus), 비피도박테리움 롱검(Bifidobacterium longum) 및 스트렙토코커스 써모필러스(Streptococcus thermophilus)로 이루어진 것일 수 있으며, 더욱 바람직하게는 7.0x1010 내지 9.0x1010 CFU/g의 비피도박테리움 애니말리스, 7.0x1010 내지 9.0x1010 CFU/g의 락토바실러스 플랜타룸, 2.0x1010 내지 4.0x1010 CFU/g의 락토바실러스 람노서스, 1.5x109 내지 3.5x109 CFU/g의 비피도박테리움 롱검 및 4.0x109 내지 6.0x109 CFU/g의 스트렙토코커스 써모필러스로 이루어진 것일 수 있으나, 이에 제한되지 않는다.In the production method according to the present invention, the mixed strain of step 3) is Bifidobacterium animalis , Lactobacillus plantarum , Lactobacillus rhamnosus , Bifidobacterium Longum ( Bifidobacterium longum ) and Streptococcus thermophilus may be composed of, and more preferably, 7.0x10 10 to 9.0x10 10 CFU/g of Bifidobacterium animalis, 7.0x10 10 to 9.0x10 10 Lactobacillus plantarum at CFU/g, Lactobacillus rhamnosus at 2.0x10 10 to 4.0x10 10 CFU/g, Bifidobacterium longum at 1.5x10 9 to 3.5x10 9 CFU/g and 4.0x10 9 to 6.0x10 9 CFU It may be made of Streptococcus thermophilus of /g, but is not limited thereto.
본 발명에 따른 상기 비피도박테리움 애니말리스는 분류체계의 변동으로 현재 비피도박테리움 락티스(Bifidobacterium lactis)로 불리운다.The Bifidobacterium animalis according to the present invention is currently called Bifidobacterium lactis due to a change in the classification system.
본 발명의 일 구현 예에 있어서, 상기 혼합균주를 1차 알로에 발효물에 접종한 뒤 35~39℃의 온도에서 4~12시간 동안 추가로 발효할 수 있다.In one embodiment of the present invention, after the mixed strain is inoculated into the primary aloe fermented product, it may be further fermented at a temperature of 35 to 39° C. for 4 to 12 hours.
본 발명에 따른 제조 방법에 있어서, 상기 증가된 유용성분은 폴리페놀 및 플라보노이드일 수 있으나, 이에 제한되지 않는다.In the manufacturing method according to the present invention, the increased useful component may be polyphenols and flavonoids, but is not limited thereto.
본 발명은 또한, 상기 방법에 의해 제조된 유용성분의 함량이 증가된 알로에 발효물을 제공한다. 본 발명에 따른 알로에 발효물은 알로에 분말 또는 알로에 겔을 유산균을 이용하여 발효시킴으로써 유용성분인 폴리페놀과 플라보노이드의 함량이 증가된 것이 특징이다.The present invention also provides an aloe fermented product having an increased content of useful ingredients prepared by the above method. The fermented aloe product according to the present invention is characterized in that the content of useful components polyphenols and flavonoids is increased by fermenting aloe powder or aloe gel using lactic acid bacteria.
본 발명은 또한, 상기 알로에 발효물 또는 이의 건조물을 유효성분으로 포함하는 포스트바이오틱스 유산균을 제공한다.The present invention also provides a postbiotic lactic acid bacterium comprising the fermented aloe or a dried product thereof as an active ingredient.
본 발명에 따른 포스트바이오틱스 유산균은 유용성분의 함량이 증가된 알로에 발효 분말을 유효성분으로 포함하는데, 상기 알로에 발효물은 전술한 것과 같다. 또한, 본 발명에 따른 알로에 발효물의 건조물은 동결 건조 공정으로 통해 제조될 수 있고 유산균이 생균의 형태로 건조물 내에 존재하는 것이 특징이다.The postbiotic lactic acid bacteria according to the present invention includes fermented aloe powder having an increased content of useful ingredients as an active ingredient, and the fermented aloe is the same as described above. In addition, the dried product of the fermented aloe according to the present invention can be prepared through a freeze-drying process, and it is characterized in that lactic acid bacteria are present in the dried product in the form of live bacteria.
본 명세서에서 용어 '포스트바이오틱스'는 유산균 배양 건조물을 의미하는 것으로, 포스트바이오틱스 유산균은 유해균을 직접적으로 사멸하고 장 점막면역을 활성화하는 것으로 알려졌다. 프로바이오틱스의 경우 장 점막에 부착한 후 유해균을 제거하는 시간이 필요하지만, 포스트바이오틱스는 장 점막 부탁의 과정을 생략할 수 있는 장점이 있다.As used herein, the term 'postbiotics' refers to lactic acid bacteria cultured dry matter, and postbiotics lactic acid bacteria are known to directly kill harmful bacteria and activate intestinal mucosal immunity. In the case of probiotics, it takes time to remove harmful bacteria after attachment to the intestinal mucosa, but postbiotics have the advantage of omitting the process of treating the intestinal mucosa.
본 발명은 또한, 상기 알로에 발효물, 이의 건조물 또는 상기 포스트바이오틱스 유산균을 유효성분으로 함유하는 건강기능식품 조성물을 제공한다.The present invention also provides a health functional food composition comprising the fermented aloe, a dried product thereof, or the postbiotic lactic acid bacteria as an active ingredient.
본 발명에 따른 건강기능식품 조성물에 있어서, 상기 알로에 발효물, 이의 건조물 또는 상기 포스트바이오틱스 유산균은 폴리페놀 및 플라보노이드 함량이 우수하고, 유산균이 생균의 형태로 존재하므로, 항산화, 비만 예방, 면역기능 증진 등 다양한 용도의 건강기능식품으로 이용될 수 있다.In the health functional food composition according to the present invention, the fermented aloe product, the dried product thereof, or the postbiotic lactic acid bacteria have excellent polyphenol and flavonoid contents, and the lactic acid bacteria exist in the form of live bacteria, so antioxidant, obesity prevention, and immune function It can be used as a health functional food for various purposes such as enhancement.
본 발명의 건강기능식품 조성물에서, 상기 식품의 종류에는 특별한 제한은 없다. 상기 알로에 발효물, 이의 건조물 또는 상기 포스트바이오틱스 유산균을 첨가할 수 있는 식품의 예로는 드링크제, 육류, 소시지, 빵, 비스킷, 떡, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 알코올 음료 및 비타민 복합제, 유제품 및 유가공 제품 등이 있으며, 통상적인 의미에서의 건강기능식품을 모두 포함한다.In the health functional food composition of the present invention, the type of the food is not particularly limited. Examples of the fermented aloe product, the dried product thereof, or the food to which the postbiotic lactic acid bacteria can be added include drinks, meat, sausage, bread, biscuits, rice cake, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, and gums. , dairy products including ice cream, various soups, beverages, alcoholic beverages and vitamin complexes, dairy products, and dairy products, and includes all health functional foods in the ordinary sense.
상기 건강기능식품은 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽, 발포정 및 음료 중에서 선택된 어느 하나의 제형으로 제조될 수 있으나, 이에 한정되지 않으며 법률에 따라 어떤 형태로든지 제조, 가공될 수 있다.The health functional food may be prepared in any one formulation selected from powder, granule, pill, tablet, capsule, candy, syrup, effervescent tablet and beverage, but is not limited thereto and may be manufactured and processed in any form according to the law. have.
본 발명의 알로에 발효물, 이의 건조물 또는 상기 포스트바이오틱스 유산균은 식품에 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합량은 그의 사용 목적에 따라 적합하게 결정될 수 있다. 일반적으로, 건강식품 중의 본 발명의 알로에 발효물, 이의 건조물 또는 상기 포스트바이오틱스 유산균은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양의로 첨가될 수 있다. 그러나 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로도 사용될 수 있다.The fermented aloe of the present invention, its dried product, or the postbiotic lactic acid bacteria may be added to food as it is or used together with other foods or food ingredients, and may be appropriately used according to a conventional method. The mixing amount of the active ingredient may be appropriately determined depending on the intended use thereof. In general, the fermented aloe in the health food, the dried product thereof, or the postbiotic lactic acid bacteria may be added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less, based on the raw material. However, in the case of long-term ingestion for health and hygiene purposes or for health control, the above amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount above the above range.
본 발명의 건강기능식품은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다. 상기 건강기능식품 조성물 외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. The health functional food of the present invention includes ingredients commonly added during food production, for example, proteins, carbohydrates, fats, nutrients and seasonings. For example, when manufactured as a drink, natural carbohydrates or flavoring agents may be included as additional ingredients in addition to the active ingredient. The natural carbohydrates include monosaccharides (eg, glucose, fructose, etc.), disaccharides (eg, maltose, sucrose, etc.), oligosaccharides, polysaccharides (eg, dextrin, cyclodextrin, etc.) or sugar alcohols (eg, , xylitol, sorbitol, erythritol, etc.). As the flavoring agent, natural flavoring agents (eg, taumatine, stevia extract, etc.) and synthetic flavoring agents (eg, saccharin, aspartame, etc.) may be used. In addition to the health functional food composition, various nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonic acid It may further contain a carbonation agent and the like used in beverages.
상기 첨가되는 성분의 비율은 크게 중요하진 않지만 본 발명의 건강기능식품 100 중량부에 대하여, 0.1 내지 1.0 중량부의 범위에서 선택되는 것이 일반적이다.Although the ratio of the added component is not very important, it is generally selected in the range of 0.1 to 1.0 parts by weight based on 100 parts by weight of the health functional food of the present invention.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of Examples. However, the following examples are only illustrative of the present invention, and the content of the present invention is not limited to the following examples.
제조예 1. 알로에 베라 분말을 활용한 발효물 및 포스트바이오틱스 유산균 제조Preparation Example 1. Preparation of fermented product and postbiotic lactic acid bacteria using aloe vera powder
1.0 ㎏의 알로에 베라 분말을 칭량하여 부직포로 만들어진 추출포에 넣은 후 10 ℓ의 정제수가 담긴 추출기에 넣고 100℃에서 24시간 동안 추출을 진행했다. 추출이 끝난 추출기로부터 여액(flitrate)을 회수하고 추출포는 압착기에 넣어 압착하여 최대한 추출물을 얻은 후 이들을 혼합하였다. 최종적으로 회수한 추출액 8 ℓ에 소이펩톤(soy peptone)과 글루코스를 각각 최종농도 1.0% 및 2.0%가 되도록 혼합한 후 110℃에서 45분간 멸균을 실시하였다. 멸균처리된 추출액은 상온까지 냉각시켰다. 이후 상기 멸균한 추출액에 1차 발효 균주인 락토바실러스 플랜타룸(Lactobacillus plantarum) CBG-C21 균주(기탁번호: KACC92083P)의 배양액(생균수 6.0x109 CFU/㎖)을 추출액의 5%(접종 후 생균수 3.0x108 CFU/㎖)로 접종하거나, 배양액의 접종과 동시에 0.2% 셀룰라아제와 0.1% 펙티나제를 처리한 후, 37℃에서 24시간 동안 80 rpm으로 교반하며 발효를 수행하였다. 이후 2차 발효를 위해 8.0x1010 CFU/g의 비피도박테리움 애니말리스 CGB-C10 (Bifidobacterium animalis CGB-C10, KCTC 11978BP; 한국등록특허 10-1446309 (공고일자 2014.10.07)), 8.0x1010 CFU/g의 락토바실러스 플랜타룸 JBMI F5(Lactobacillus plantarum JBMI F5, KACC91638P; 한국등록특허 10-1683478 (공고일자 2016.12.08)), 3.0x1010 CFU/g의 락토바실러스 람노서스 CBG-C14 (L. rhamnosus CBG-C14, KACC91981P; 한국등록특허 10-2032033 (공고일자 2019.10.14)), 2.5x109 CFU/g의 비피도박테리움 롱검 CGB-C11 (B. longum CGB-C11, KCTC 11979BP; 한국등록특허 10-1401530 (공고일자 2014.06.11)) 및 5x109 CFU/g의 스트렙토코커스 써모필러스 CBG-C19 (Streptococcus thermophilus CBG-C19, KACC91986P; 한국등록특허 10-1655856 (공고일자 2016.09.08)) 균주 분말을 동시에 접종하여 37℃에서 8시간 동안 발효하고 배양이 완료된 알로에 베라 분말 발효물은 동결건조하여 분말화 하였다.1.0 kg of aloe vera powder was weighed and placed in an extraction cloth made of non-woven fabric, and then placed in an extractor containing 10 liters of purified water and extraction was performed at 100° C. for 24 hours. After the extraction was completed, the filtrate (flitrate) was recovered from the extractor, and the extract cloth was put into a press and compressed to obtain an extract as much as possible, and then they were mixed. Finally, 8 ℓ of the recovered extract was mixed with soy peptone and glucose to have final concentrations of 1.0% and 2.0%, respectively, and then sterilized at 110° C. for 45 minutes. The sterilized extract was cooled to room temperature. Afterwards, the culture solution (viable number 6.0x10 9 CFU/ml) of the Lactobacillus plantarum CBG-C21 strain (accession number: KACC92083P), which is the primary fermentation strain, was added to the sterilized extract 5% of the extract (live cells after inoculation) 3.0x10 8 CFU/ml) or treated with 0.2% cellulase and 0.1% pectinase at the same time as the inoculation of the culture medium, and then fermented with stirring at 80 rpm for 24 hours at 37°C. Bifidobacterium animalis CGB-C10 ( Bifidobacterium animalis CGB-C10, KCTC 11978BP; Korean Patent 10-1446309 (published on October 7, 2014)) of 8.0x10 10 CFU/g for secondary fermentation, 8.0x10 10 CFU / g of Lactobacillus plantarum JBMI F5 ( Lactobacillus plantarum JBMI F5, KACC91638P; Korean Patent 10-1683478 (published on December 8, 2016)), 3.0x10 10 CFU / g of Lactobacillus rhamnosus CBG-C14 ( L. rhamnosus CBG-C14, KACC91981P; Korean Patent No. 10-2032033 (published October 14, 2019)), Bifidobacterium longum CGB-C11 ( B. longum CGB-C11, KCTC 11979BP; Korean registration of 2.5x10 9 CFU/g) Patent 10-1401530 (published Jun. 11, 2014) and 5x10 9 CFU/g of Streptococcus thermophilus CBG-C19 ( Streptococcus thermophilus CBG-C19, KACC91986P; Korean Patent No. 10-1655856 (published Aug. 8, 2016)) The strain powder was simultaneously inoculated, fermented at 37° C. for 8 hours, and the cultured Aloe vera powder fermented product was freeze-dried and powdered.
유산균 단독 발효에 의해 제조된 알로에 베라 분말 발효물 분말은 '알로에 베라 발효 분말'로, 유산균 및 효소 처리에 의해 제조된 알로에 베라 분말 효소처리 발효 분말은 '알로에 베라 효소처리 발효 분말'로 명명하였다.Aloe vera powder fermented powder produced by lactic acid bacteria alone fermentation was named 'Aloe vera fermented powder', and Aloe vera powder enzyme-treated fermented powder prepared by lactic acid bacteria and enzyme treatment was named 'Aloe vera enzyme-treated fermented powder'.
제조예 2. 알로에 아보레센스 분말을 활용한 발효물 및 포스트바이오틱스 유산균 제조Preparation Example 2. Preparation of fermented product and postbiotic lactic acid bacteria using aloe aborescens powder
상기 제조예 1과 동일한 방법으로 수행하되, 알로에 베라 분말 대신 알로에 아보레센스 분말을 사용하였다.It was carried out in the same manner as in Preparation Example 1, except that aloe vera powder was used instead of aloe vera powder.
유산균 단독 발효에 의해 제조된 알로에 아보레센스 분말 발효물 분말은 '알로에 아보레센스 발효 분말'로, 유산균 및 효소 처리에 의해 제조된 알로에 아보레센스 분말 효소처리 발효 분말은 '알로에 아보레센스 효소처리 발효 분말'로 명명하였다.Aloe aborescens powder fermented powder produced by single fermentation of lactic acid bacteria is 'Aloe aborescens fermented powder', and 'Aloe aborescens fermented powder' named as
제조예 3. 알로에 베라 겔을 활용한 발효물 및 포스트바이오틱스 유산균 제조Preparation Example 3. Preparation of fermented product and postbiotic lactic acid bacteria using aloe vera gel
1.0 ㎏의 알로에 베라 겔을 칭량하여 1ℓ의 정제수에 넣은 혼합액 2ℓ에 최종농도가 각각 1.0% 및 2.0%가 되도록 소이펩톤과 글루코스를 혼합한 후 110℃에서 45분간 멸균을 실시하였다. 멸균처리된 알로에 겔 액은 상온까지 냉각시켰다. 이후 상기 멸균한 겔 액에 1차 발효 균주인 락토바실러스 플랜타룸 CBG-C21 균주(기탁번호: KACC92083P)의 배양액(생균수 6.0x109 CFU/㎖)을 추출액의 5%(접종 후 생균수 3.0x108 CFU/㎖)로 접종하거나, 배양액의 접종과 동시에 0.2% 셀룰라아제와 0.1% 펙티나제를 처리한 후, 37℃에서 24시간 동안 80 rpm으로 교반하며 발효를 수행하였다. 이후 2차 발효를 위해 비피도박테리움 애니말리스(8.0x1010 CFU/g), 락토바실러스 플랜타룸(8.0x1010 CFU/g), 락토바실러스 람노서스(3.0x1010 CFU/g), 비피도박테리움 롱검(2.5x109 CFU/g) 및 스트렙토코커스 써모필러스(5x109 CFU/g) 균주 분말을 동시에 접종하여 37℃에서 8시간 동안 발효하고 배양이 완료된 알로에 베라 겔 발효물은 동결건조하여 분말화 하였다. 상기 각 균주는 실시예 1과 동일하다.1.0 kg of aloe vera gel was weighed and mixed with soipeptone and glucose so that the final concentrations were 1.0% and 2.0%, respectively, in 2L of the mixture added to 1L of purified water, and then sterilized at 110°C for 45 minutes. The sterilized aloe gel solution was cooled to room temperature. Then, the culture solution (viable number 6.0x10 9 CFU/ml) of the Lactobacillus plantarum CBG-C21 strain (Accession No.: KACC92083P), the primary fermentation strain, was added to the sterilized gel solution with 5% of the extract (the number of viable cells after inoculation 3.0x10) 8 CFU/ml), or after treatment with 0.2% cellulase and 0.1% pectinase at the same time as inoculation of the culture medium, fermentation was performed while stirring at 80 rpm at 37°C for 24 hours. For secondary fermentation, Bifidobacterium animalis (8.0x10 10 CFU/g), Lactobacillus plantarum (8.0x10 10 CFU/g), Lactobacillus rhamnosus (3.0x10 10 CFU/g), Bifidobacterium Leeum longum (2.5x10 9 CFU/g) and Streptococcus thermophilus (5x10 9 CFU/g) strain powder were simultaneously inoculated and fermented at 37°C for 8 hours. got angry Each of the above strains is the same as in Example 1.
유산균 단독 발효에 의해 제조된 알로에 베라 겔 발효물 분말은 '알로에 베라 겔 발효 분말'로, 유산균 및 효소 처리에 의해 제조된 알로에 베라 겔 효소처리 발효 분말은 '알로에 베라 겔 효소처리 발효 분말'로 명명하였다.Aloe vera gel fermented powder produced by lactic acid bacteria alone fermentation is called 'Aloe vera gel fermented powder', and aloe vera gel enzyme-treated fermented powder produced by lactic acid bacteria and enzyme treatment is named 'Aloe vera gel enzyme-treated fermented powder'. did.
제조예 4. 알로에 아보레센스 겔을 활용한 발효물 및 포스트바이오틱스 유산균 제조Preparation Example 4. Preparation of fermented product and postbiotic lactic acid bacteria using Aloe aborescens gel
상기 제조예 3과 동일한 방법으로 수행하되, 알로에 베라 겔 대신 알로에 아보레센스 겔을 사용하였다.It was carried out in the same manner as in Preparation Example 3, except that Aloe aborescens gel was used instead of Aloe vera gel.
유산균 단독 발효에 의해 제조된 알로에 아보레센스 겔 발효물 분말은 '알로에 아보레센스 겔 발효 분말'로, 유산균 및 효소 처리에 의해 제조된 알로에 아보레센스 겔 효소처리 발효 분말은 '알로에 아보레센스 겔 효소처리 발효 분말'로 명명하였다.Aloe aborescens gel fermented powder produced by single fermentation of lactic acid bacteria is 'Aloe aborescens gel fermented powder', and Aloe aborescens gel enzyme-treated fermented powder produced by lactic acid bacteria and enzyme treatment is 'Aloe aborescens gel enzymatic fermentation. powder'.
실시예 1. 알로에 발효물 내의 생균수 분석Example 1. Analysis of the number of viable cells in fermented aloe
상기 제조예 1 내지 4에서 제조한 각각의 발효물 분말 내 생균수를 분석하였다(표 1).The number of viable cells in each of the fermented powders prepared in Preparation Examples 1 to 4 was analyzed (Table 1).
실시예 2. 알로에 발효물의 유용성분 함량 분석Example 2. Analysis of the content of useful components in fermented aloe
상기 제조예 1 내지 4에서 제조한 각각의 발효물 분말 내 항산화 관련 유용성분인 총 폴리페놀, 총 플라보노이드 함량을 측정하였다. The contents of total polyphenols and total flavonoids, which are antioxidant-related useful components, in each of the fermented powders prepared in Preparation Examples 1 to 4 were measured.
총 폴리페놀 함량 측정은 싱글톤 및 로시의 방법(Singleton, V. and Rossi, J et al., 1965, American Journal of Enology and Viticulture, 16, 144-158)을 일부 변형하여 측정하였다. 알로에 분말 또는 겔과 각각의 발효물 각 1.0 g을 70% 메탄올 5.0 ㎖과 혼합한 후 초음파 수조에서 1시간 동안 추출을 실시하였다. 추출이 완료된 시료는 원심분리를 통해 상등액만을 취하여 분석에 사용하였다. 준비된 시료액 및 갈산 표준물질(20, 40, 60, 80, 100 ㎎/ℓ) 1.0 ㎖을 각각 9.0 ㎖의 3차 증류수가 들어 있는 25 ㎖ 정량 플라스크에 넣고 페놀용액(Folin-ciocalteu's phenol reagent) 1.0 ㎖을 첨가하였다. 5분 후 7% Na2CO3 용액 10 ㎖을 가하여 충분히 교반한 다음 3차 증류수로 25 ㎖을 채워서 혼합하여 23℃에서 90분간 반응시킨 후 750 nm에서 blank를 대조로 하여 흡광도를 측정하였다. 이때 표준 검량 곡선은 표준 물질로서 갈산(gallic acid)을 일정 농도로 하여 상기와 동일한 방법으로 측정하여 획득하였으며, 시료의 흡광도를 표준 검량 곡선에 대입하여 총 페놀 함량을 ㎍/g로 나타내었다.The total polyphenol content was measured with some modifications of the Singleton and Rossi method (Singleton, V. and Rossi, J et al., 1965, American Journal of Enology and Viticulture, 16, 144-158). Aloe powder or gel and 1.0 g of each fermented product were mixed with 5.0 ml of 70% methanol, followed by extraction in an ultrasonic water bath for 1 hour. After the extraction was completed, only the supernatant was collected through centrifugation and used for analysis. Put 1.0 ml of the prepared sample solution and gallic acid standard (20, 40, 60, 80, 100 mg/ℓ) into a 25 ml quantitative flask containing 9.0 ml of tertiary distilled water, respectively, and 1.0 ml of phenol solution (Folin-ciocalteu's phenol reagent) ml was added. After 5 minutes, 10 ml of a 7% Na 2 CO 3 solution was added, stirred sufficiently, and then filled with 25 ml of tertiary distilled water, mixed, and reacted at 23° C. for 90 minutes. Absorbance was measured at 750 nm using a blank as a control. At this time, the standard calibration curve was obtained by measuring in the same manner as above using gallic acid as a standard material at a constant concentration, and substituting the absorbance of the sample into the standard calibration curve to represent the total phenol content in μg/g.
총 플라보노이드 함량은 지센의 방법(Zhishen J. et al., 1999, Food Chemistry, v.64, p.555-559)을 변형하여 측정하였다. 알로에 분말 또는 겔과 각각의 발효물 1.0 g을 70% 메탄올 5.0 ㎖과 혼합한 후 초음파 수조에서 1시간 동안 추출을 실시하였다. 추출이 완료된 시료는 원심분리를 통해 상등액만을 취해 분석에 사용하였다. 준비된 시료액 및 퀘세틴 표준물질(20, 40, 60, 80, 100 ㎎/ℓ) 1.0 ㎖을 각각 4.0 ㎖의 3차 증류수가 들어있는 10 ㎖ 정량 플라스크에 넣고 제로 타임에 5% NaNO2를 0.3 ㎖을 첨가하여 충분히 교반하였다. 5분 후 10% AlCl3을 0.3 ㎖ 넣어주고 6분 후 1M NaOH를 2.0 ㎖ 첨가하고 즉시 3차 증류수를 2.4 ㎖ 첨가하여 완전히 혼합한 후 실온에서 1분간 반응시킨 다음 UV/Vis Spectrometer를 이용하여 510 nm에서 blank를 대조로 하여 각 용액의 흡광도를 측정하였다. 이때 총 플라보노이드 함량은 표준 물질로서 퀘세틴(quercetin)을 일정 농도로 하여 상기와 동일한 방법으로 측정하여 획득하였으며, 시료의 흡광도를 표준 검량 곡선에 대입하여 총 플라보노이드 함량을 ㎍/g로 나타내었다.Total flavonoid content was determined by modifying the method of Zhishen J. et al., 1999, Food Chemistry, v.64, p.555-559. Aloe powder or gel and 1.0 g of each fermented product were mixed with 5.0 ml of 70% methanol, followed by extraction in an ultrasonic water bath for 1 hour. After the extraction was completed, only the supernatant was collected through centrifugation and used for analysis. Put 1.0 ml of prepared sample solution and quercetin standard (20, 40, 60, 80, 100 mg/ℓ) into a 10 ml quantitative flask containing 4.0 ml of tertiary distilled water, respectively, and add 5% NaNO 2 to 0.3 at zero time. mL was added and the mixture was sufficiently stirred. After 5 minutes, 0.3 mL of 10% AlCl 3 was added, and after 6 minutes, 2.0 mL of 1M NaOH was added. Immediately, 2.4 mL of tertiary distilled water was added, thoroughly mixed, and reacted at room temperature for 1 minute, followed by 510 using a UV/Vis Spectrometer. The absorbance of each solution was measured using the blank as a control in nm. At this time, the total flavonoid content was obtained by measuring in the same manner as above using a certain concentration of quercetin as a standard material, and substituting the absorbance of the sample into a standard calibration curve to express the total flavonoid content as μg/g.
그 결과, 하기 표 2 내지 5에서와 같이 유산균 발효에 의해 알로에 분말 또는 겔 발효물 모두 발효 전과 비교하여 총 폴리페놀 및 총 플라보노이드 함량이 증가되는 것으로 확인되었으며, 특히 총 폴리페놀의 함량 증진 효과가 우수한 것으로 나타났다.As a result, as shown in Tables 2 to 5 below, it was confirmed that the total polyphenol and total flavonoid contents were increased by lactic acid bacteria fermentation in both aloe powder or gel fermented products compared to before fermentation. appeared to be
실시예 3. 알로에 발효물의 항산화 활성 분석Example 3. Analysis of Antioxidant Activity of Fermented Aloe
상기 제조예 1 내지 4에서 제조한 각각의 발효물 분말 내 항산화 활성을 평가하기 위해, ABTS 및 DPPH 활성 분석을 수행하였다. 알로에 분말 또는 겔과 각각의 발효물 각 1.0 g을 70% 메탄올 5.0 ㎖과 혼합한 후 초음파 수조에서 1시간 동안 추출을 실시하고, 원심분리 후 상등액만을 취하여 분석에 사용하였다.In order to evaluate the antioxidant activity in each of the fermented powders prepared in Preparation Examples 1 to 4, ABTS and DPPH activity assays were performed. After mixing 1.0 g each of aloe powder or gel and each fermented product with 5.0 ml of 70% methanol, extraction was performed in an ultrasonic water bath for 1 hour, and after centrifugation, only the supernatant was collected and used for analysis.
ABTS 활성 분석은 증류수에 녹인 80 mM ABTS(2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid))와 30 mM Potassium persulfate 용액 각 1.0 ㎖과 증류수 8.0 ㎖을 혼합하여 30℃ 암실에서 1시간 반응시킨 후 734 nm에서 흡광도 0.8이 되도록 희석하여 ABTS+ 용액을 준비하였다. 이 후, 각각의 시료 100 ㎕와 ABTS+ 용액 900 ㎕을 혼합하여 37℃, 암실에서 30분간 반응을 실시한 후 734 nm에서 흡광도를 측정하였고, 활성비교를 위하여 Trolox (Sigma-Aldrich)를 메탄올을 사용하여 농도 10 ㎎/㎖로 제조하여 양성대조구로 사용하였다.ABTS activity assay was performed by mixing 1.0 ml each of 80 mM ABTS (2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)) and 30 mM Potassium persulfate solution in distilled water and 8.0 ml of distilled water in a dark room at 30°C. After reacting for 1 hour, the ABTS+ solution was prepared by diluting it to have an absorbance of 0.8 at 734 nm. After that, 100 μl of each sample and 900 μl of ABTS+ solution were mixed and reacted in the dark at 37° C. for 30 minutes, and absorbance was measured at 734 nm. For activity comparison, Trolox (Sigma-Aldrich) was used with methanol. It was prepared at a concentration of 10 mg/ml and used as a positive control.
DPPH 활성 분석은 에탄올에 녹인 0.5 mM DPPH(2,2-Diphenyl-1- picrylhydrazyl)를 사용하였다. 각각의 시료 200 ㎕와 DPPH를 800 ㎕로 혼합하여 상온의 암실에서 30분간 반응을 실시한 후 분광광도계를 활용하여 517 nm에서 흡광도를 측정하였고, 활성비교를 위하여 아스코빅산(Sigma-Aldrich)을 에탄올을 사용하여 농도 10 ㎎/㎖로 제조하여 양성대조구로 사용하였다.For DPPH activity analysis, 0.5 mM DPPH (2,2-Diphenyl-1-picrylhydrazyl) dissolved in ethanol was used. 200 μl of each sample and 800 μl of DPPH were mixed and reacted for 30 minutes in a dark room at room temperature, then absorbance was measured at 517 nm using a spectrophotometer. For activity comparison, ascorbic acid (Sigma-Aldrich) was added with ethanol was used as a positive control to prepare a concentration of 10 mg/ml using
분석 결과, 하기 표 6 내지 9에서와 같이 유산균 발효에 의해 알로에 분말 또는 겔 발효물 모두 발효 전과 비교하여 항산화 활성이 증가된 것을 알 수 있었다.As a result of the analysis, as shown in Tables 6 to 9 below, it was found that both the aloe powder or the gel fermented product by lactic acid bacteria had increased antioxidant activity compared to that before fermentation.
Claims (10)
2) 상기 1) 단계의 알로에 혼합물에 유산균을 접종하여 1차 발효하는 단계; 및
3) 상기 2) 단계의 알로에 발효물에 혼합균주를 접종하여 2차 발효하는 단계;를 포함하는 유용성분의 함량이 증가된 알로에 발효물의 제조 방법.1) preparing a mixture of aloe and edible medium;
2) inoculating lactic acid bacteria into the aloe mixture of step 1) and performing primary fermentation; and
3) A method for producing a fermented aloe with an increased content of useful components, comprising: inoculating the fermented aloe of step 2) with a mixed strain and performing secondary fermentation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210040699 | 2021-03-29 | ||
KR20210040699 | 2021-03-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220136107A true KR20220136107A (en) | 2022-10-07 |
Family
ID=83595548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220026498A KR20220136107A (en) | 2021-03-29 | 2022-03-02 | Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220136107A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116350563A (en) * | 2023-05-12 | 2023-06-30 | 广东迪美新材料科技有限公司 | Plant co-fermentation composition and preparation method and application thereof |
KR102653830B1 (en) | 2023-12-28 | 2024-04-02 | 홍영선 | Composition for improving hair loss and scalp irritation caused by ultraviolet rays containing fermented Aloe aborescens extract |
-
2022
- 2022-03-02 KR KR1020220026498A patent/KR20220136107A/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116350563A (en) * | 2023-05-12 | 2023-06-30 | 广东迪美新材料科技有限公司 | Plant co-fermentation composition and preparation method and application thereof |
CN116350563B (en) * | 2023-05-12 | 2023-08-04 | 广东迪美新材料科技有限公司 | Plant co-fermentation composition and preparation method and application thereof |
KR102653830B1 (en) | 2023-12-28 | 2024-04-02 | 홍영선 | Composition for improving hair loss and scalp irritation caused by ultraviolet rays containing fermented Aloe aborescens extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20120263704A1 (en) | Powdery malted rice extract composition | |
KR101467837B1 (en) | Manufacturing method of fermented red ginseng extract with enhanced ginsenosides Rg3 and antioxidant activity | |
KR20220136107A (en) | Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same | |
KR20220025679A (en) | Method for producing fermented apple postbiotics with increased effective component content using lactic acid bacteria | |
KR20220025680A (en) | Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria | |
KR101409764B1 (en) | Comprising lactic acid fermentation product of Gelidium amansil extract as an Active Ingredient for Improving Skin Wrinkle | |
KR20200139876A (en) | Manufacturing method of healthy beverage containing improvement of gastric disease by using the cabbage extracts | |
KR20200083710A (en) | Composition containing an fermentation extract of zanthoxylum schinifolium as an active ingredient and its use | |
KR102394733B1 (en) | Method for producing fermented spinach and fermented soybean with increased effective component content using lactic acid bacteria | |
KR20170120264A (en) | Fermented chestnut puree of probiotic lactic acid bacteria and foods composition, medicinal composition including the same | |
TWI734322B (en) | Kimchi for prevention or treatment of disease related to helicobacter pylori | |
KR102230517B1 (en) | Lactobacillus salivarius having anticariogenic activities and composition comprising the same | |
KR100773059B1 (en) | Novel microorganism having deglycosylating ability, the probiotics containing the same and the process for preparing them | |
KR101871169B1 (en) | New kimchi lactic acid bacteria Weissella cibaria MFST and composition using concentrated extract of Ziziphus jujuba seed | |
KR20220025681A (en) | Method for producing fermented cranberry postbiotics with increased effective component content using lactic acid bacteria | |
KR20200078171A (en) | The manufacturing method of fermented red ginseng extracts enhanced with ginsenoside compound K, Rd and Rd3 using β-glucosidase and lactic acid bacteria | |
KR20220025678A (en) | Method for producing fermented barley sprout postbiotics with increased effective component content using lactic acid bacteria | |
KR102210092B1 (en) | Lactobacillus reuteri MG505 having anticariogenic activities and composition comprising the same | |
KR101794637B1 (en) | Fermentation Process of a Garlic Using New Strain of Bacillus subtilis | |
KR102042151B1 (en) | A composition as a prebiotic for improving intestinal microflora containing extract from pepper leaves | |
KR101482044B1 (en) | Food composition comprising fermented product of Pleuropterus multiflorus and ginger for alleviating or preventing degenerative brain disorder and method of producing the same | |
KR101768817B1 (en) | Food composition for anti-oxidation and inhanced immunity comprising chamomile flower extract short-term fermented by lactic acid bacteria and the method of preparation thereof | |
KR20220011937A (en) | Lactobacillus paracasei GFC_GFV5 for removing hangover and food composition comprising the same as an effective ingredient | |
KR20200083712A (en) | Composition containing an mixed fermentation extract of rubus coreanus, soy bean and zanthoxylum schinifolium as an active ingredient and its use | |
KR102401490B1 (en) | Compositions containing Angelica gigas extract |